Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of Jan 20
 -0.51 / -0.54%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.


1 month-0.60% 3 years+7.26%
3 months+3.76% 5 years+20.38%
1 year-1.02% Since inception+15.86%
Data through 01/21/2017

Quote Details

Previous close$94.35
Open day’s range93.56 – 94.53
Net asset value (NAV)93.83 (01/20/2017)
Daily volume78,752
Average volume (3 months)79,386
Data as of 01/20/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+20.38%+16.84%
Expense Gross exp ratio0.55%1.32%
Risk 5 year sharpe ratio0.941.08
Net assets$804.4M$2.8B
Average market cap$8.9B$32.0B
Average P/E20.119.5
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IONS Ionis Pharmaceuticals Inc5.70%
UTHR United Therapeutics Corp4.25%
CELG Celgene3.89%
INCY Incyte Corp3.83%
ACAD ACADIA Pharmaceuticals Inc3.74%
-- 3.58%
RARE Ultragenyx Pharmaceutical Inc3.48%
SGEN Seattle Genetics Inc3.46%
GRFS Grifols SA3.45%
ALNY Alnylam Pharmaceuticals Inc3.42%

Search for Jobs